Pulse Biosciences, Inc. (PLSE)
NASDAQ: PLSE · Real-Time Price · USD
13.27
0.00 (0.00%)
At close: Dec 5, 2025, 4:00 PM EST
13.31
+0.04 (0.30%)
After-hours: Dec 5, 2025, 5:27 PM EST
Pulse Biosciences Market Cap
Pulse Biosciences has a market cap or net worth of $899.28 million as of December 5, 2025. Its market cap has decreased by -11.30% in one year.
Market Cap
899.28M
Enterprise Value
811.95M
1-Year Change
-11.30%
Ranking
Category
Stock Price
$13.27
Market Cap Chart
Since May 18, 2016, Pulse Biosciences's market cap has increased from $52.40M to $899.28M, an increase of 1,616.18%. That is a compound annual growth rate of 34.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 899.30M | -16.03% |
| Dec 31, 2024 | 1.07B | 59.11% |
| Dec 29, 2023 | 673.10M | 552.86% |
| Dec 30, 2022 | 103.10M | -76.50% |
| Dec 31, 2021 | 438.80M | -27.42% |
| Dec 31, 2020 | 604.60M | 116.86% |
| Dec 31, 2019 | 278.80M | 43.19% |
| Dec 31, 2018 | 194.70M | -49.52% |
| Dec 29, 2017 | 385.70M | 345.90% |
| Dec 30, 2016 | 86.50M | 65.08% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |